Open Access

PCSK9-Inhibitions: for whom, when, and how effective.

Congress Presentation

About the speaker

Professor Christoph Saely

VIVIT Institute, Feldkirch (Austria)
2 presentations
0 follower

3 more presentations in this session

Distribution of estimated 10-year risk of recurrent vascular events and residual risk in a secondary prevention population.

Speaker: Professor F. Visseren (Utrecht, NL)


Individual decision for length of dual antiplatelet therapy after ACS.

Speaker: Professor P. Clemmensen (Hamburg, DE)


New antidiabetic agents reduce cardiovascular events.

Speaker: Associate Professor J. Schmid (Gais, CH)


Access the full session

Secondary Prevention: unmet medical needs - Session I

Speakers: Professor C. Saely, Professor F. Visseren, Professor P. Clemmensen, Associate Professor J. Schmid

About the event


EuroPrevent 2017

6 April - 8 April 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb